Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1988 May;148(5):561–567.

Pheochromocytoma—Recent Advances in Diagnosis and Treatment

PMCID: PMC1026174  PMID: 3176460

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Drs Homer A. Boushey, Professor of Medicine, and David G. Warnock, Associate Professor of Medicine, under the direction of Dr Lloyd H. Smith, Jr, Professor of Medicine and Associate Dean in the School of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.

Full text

PDF
561

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRUNJES S., JOHNS V. J., Jr, CRANE M. G. Pheochromocytoma: postoperative shock and blood volume. N Engl J Med. 1960 Feb 25;262:393–396. doi: 10.1056/NEJM196002252620805. [DOI] [PubMed] [Google Scholar]
  2. Blum R. Enalapril in pheochromocytoma. Ann Intern Med. 1987 Feb;106(2):326–327. doi: 10.7326/0003-4819-106-2-326_2. [DOI] [PubMed] [Google Scholar]
  3. Bouloux P. M., Grossman A., Besser G. M. Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas. Clin Endocrinol (Oxf) 1986 Mar;24(3):319–325. doi: 10.1111/j.1365-2265.1986.tb03273.x. [DOI] [PubMed] [Google Scholar]
  4. Bravo E. L., Gifford R. W., Jr Current concepts. Pheochromocytoma: diagnosis, localization and management. N Engl J Med. 1984 Nov 15;311(20):1298–1303. doi: 10.1056/NEJM198411153112007. [DOI] [PubMed] [Google Scholar]
  5. Bravo E. L., Tarazi R. C., Fouad F. M., Textor S. C., Gifford R. W., Jr, Vidt D. G. Blood pressure regulation in pheochromocytoma. Hypertension. 1982 May-Jun;4(3 Pt 2):193–199. [PubMed] [Google Scholar]
  6. Bravo E. L., Tarazi R. C., Fouad F. M., Vidt D. G., Gifford R. W., Jr Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma. N Engl J Med. 1981 Sep 10;305(11):623–626. doi: 10.1056/NEJM198109103051107. [DOI] [PubMed] [Google Scholar]
  7. Bravo E. L., Tarazi R. C., Gifford R. W., Stewart B. H. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med. 1979 Sep 27;301(13):682–686. doi: 10.1056/NEJM197909273011302. [DOI] [PubMed] [Google Scholar]
  8. Chatal J. F., Charbonnel B. Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma. J Clin Endocrinol Metab. 1985 Oct;61(4):769–772. doi: 10.1210/jcem-61-4-769. [DOI] [PubMed] [Google Scholar]
  9. Cohen C. D., Dent D. M. Phaeochromocytoma and acute cardiovascular death (with special reference to myocardial infarction). Postgrad Med J. 1984 Feb;60(700):111–115. doi: 10.1136/pgmj.60.700.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fink I. J., Reinig J. W., Dwyer A. J., Doppman J. L., Linehan W. M., Keiser H. R. MR imaging of pheochromocytomas. J Comput Assist Tomogr. 1985 May-Jun;9(3):454–458. doi: 10.1097/00004728-198505000-00006. [DOI] [PubMed] [Google Scholar]
  11. GIFFORD R. W., Jr, KVALE W. F., MAHER F. T., ROTH G. M., PRIESTLEY J. T. CLINICAL FEATURES, DIAGNOSIS AND TREATMENT OF PHEOCHROMOCYTOMA: A REVIEW OF 76 CASES. Mayo Clin Proc. 1964 Apr;39:281–302. [PubMed] [Google Scholar]
  12. Jones N. F., Walker G., Ruthven C. R., Sandler M. Alpha-methyl-p-tyrosine in the management of phaeochromocytoma. Lancet. 1968 Nov 23;2(7578):1105–1109. doi: 10.1016/s0140-6736(68)91579-1. [DOI] [PubMed] [Google Scholar]
  13. Kaufman L. Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma. Br J Clin Pharmacol. 1979;8(Suppl 2):229S–232S. [PMC free article] [PubMed] [Google Scholar]
  14. Kirby B. D., Ham J., Fairley H. B., Benowitz N., Schambelan M. Normotensive pheochromocytoma. Pharmacologic, paraneoplastic and anesthetic considerations. West J Med. 1983 Aug;139(2):221–225. [PMC free article] [PubMed] [Google Scholar]
  15. Kuchel O., Buu N. T., Fontaine A., Hamet P., Beroniade V., Larochelle P., Genest J. Free and conjugated plasma catecholamines in hypertensive patients with and without pheochromocytoma. Hypertension. 1980 Mar-Apr;2(2):177–186. doi: 10.1161/01.hyp.2.2.177. [DOI] [PubMed] [Google Scholar]
  16. Lam J. B., Shub C., Sheps S. G. Reversible dilatation of hypertrophied left ventricle in pheochromocytoma: serial two-dimensional echocardiographic observations. Am Heart J. 1985 Mar;109(3 Pt 1):613–615. doi: 10.1016/0002-8703(85)90580-0. [DOI] [PubMed] [Google Scholar]
  17. Levister E. C., Jr, Taylor J. B. Physiological hypertrophic subaortic stenosis and subendocardial infarction in a patient with a pheochromocytoma. J Natl Med Assoc. 1981 Apr;73(4):357–361. [PMC free article] [PubMed] [Google Scholar]
  18. Louis W. J., Doyle A. E., Heath W. C., Robinson M. J. Secretion of dopa in phaeochromocytoma. Br Med J. 1972 Nov 11;4(5836):325–327. doi: 10.1136/bmj.4.5836.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mannelli M., DeFeo M. L., Maggi M., Geppetti P., Baldi E., Pupilli C., Serio M. Effect of verapamil on catecholamine secretion by human pheochromocytoma. Hypertension. 1986 Sep;8(9):813–814. doi: 10.1161/01.hyp.8.9.813. [DOI] [PubMed] [Google Scholar]
  20. Nicholson J. P., Jr, Vaughn E. D., Jr, Pickering T. G., Resnick L. M., Artusio J., Kleinert H. D., Lopez-Overjero J. A., Laragh J. H. Pheochromocytoma and prazosin. Ann Intern Med. 1983 Oct;99(4):477–479. doi: 10.7326/0003-4819-99-4-477. [DOI] [PubMed] [Google Scholar]
  21. O'Connor D. T., Deftos L. J. Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med. 1986 May 1;314(18):1145–1151. doi: 10.1056/NEJM198605013141803. [DOI] [PubMed] [Google Scholar]
  22. Proye C., Fossati P., Fontaine P., Lefebvre J., Decoulx M., Wemeau J. L., Dewailly D., Rwamasirabo E., Cecat P. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery. 1986 Dec;100(6):1154–1162. [PubMed] [Google Scholar]
  23. Reinig J. W., Doppman J. L., Dwyer A. J., Johnson A. R., Knop R. H. Adrenal masses differentiated by MR. Radiology. 1986 Jan;158(1):81–84. doi: 10.1148/radiology.158.1.3940403. [DOI] [PubMed] [Google Scholar]
  24. Serfas D., Shoback D. M., Lorell B. H. Phaeochromocytoma and hypertrophic cardiomyopathy: apparent suppression of symptoms and noradrenaline secretion by calcium-channel blockade. Lancet. 1983 Sep 24;2(8352):711–713. doi: 10.1016/s0140-6736(83)92250-x. [DOI] [PubMed] [Google Scholar]
  25. Shub C., Cueto-Garcia L., Sheps S. G., Ilstrup D. M., Tajik A. J. Echocardiographic findings in pheochromocytoma. Am J Cardiol. 1986 Apr 15;57(11):971–975. doi: 10.1016/0002-9149(86)90741-1. [DOI] [PubMed] [Google Scholar]
  26. Sloand E. M., Thompson B. T. Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. Arch Intern Med. 1984 Jan;144(1):173–174. [PubMed] [Google Scholar]
  27. Stenström G., Haljamäe H., Tisell L. E. Influence of pre-operative treatment with phenoxybenzamine on the incidence of adverse cardiovascular reactions during anaesthesia and surgery for phaeochromocytoma. Acta Anaesthesiol Scand. 1985 Nov;29(8):797–803. doi: 10.1111/j.1399-6576.1985.tb02303.x. [DOI] [PubMed] [Google Scholar]
  28. Stenström G., Holmberg S. Cardiomyopathy in phaeochromocytoma: report of a case with a 16-year follow-up after surgery and review of the literature. Eur Heart J. 1985 Jun;6(6):539–544. doi: 10.1093/oxfordjournals.eurheartj.a061900. [DOI] [PubMed] [Google Scholar]
  29. Sutton M. G., Sheps S. G., Lie J. T. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc. 1981 Jun;56(6):354–360. [PubMed] [Google Scholar]
  30. Swensen S. J., Brown M. L., Sheps S. G., Sizemore G. W., Gharib H., Grant C. S., van Heerden J. A. Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma. Mayo Clin Proc. 1985 May;60(5):299–304. doi: 10.1016/s0025-6196(12)60536-9. [DOI] [PubMed] [Google Scholar]
  31. Tsujimoto G., Manger W. M., Hoffman B. B. Desensitization of beta-adrenergic receptors by pheochromocytoma. Endocrinology. 1984 Apr;114(4):1272–1278. doi: 10.1210/endo-114-4-1272. [DOI] [PubMed] [Google Scholar]
  32. Van Vliet P. D., Burchell H. B., Titus J. L. Focal myocarditis associated with pheochromocytoma. N Engl J Med. 1966 May 19;274(20):1102–1108. doi: 10.1056/NEJM196605192742002. [DOI] [PubMed] [Google Scholar]
  33. van Heerden J. A., Sheps S. G., Hamberger B., Sheedy P. F., 2nd, Poston J. G., ReMine W. H. Pheochromocytoma: current status and changing trends. Surgery. 1982 Apr;91(4):367–373. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES